Biopolym. Cell. 2003; 19(3):287-291.
http://dx.doi.org/10.7124/bc.00065E
Bioorganic Chemistry
Search for antitumor activity among derivatives of the 2,5-dihydropyrrole-2,5-dione
1Tarnavskiy S. S., 1Dubinina G. G., 1Golovach S. M., 1Yarmoluk S. M.
  1. Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680

Abstract

39 derivatives of the 2,5-dihydropyrrole-2,5-dione were synthesized and tested on antitumor activity. The l-benzyl-3-chloro-4-(3-hydro-xyanilino)-2,5-dihydro-IH-2,5-pyrroledione (5.2) was selected after pre-screening and tested on 56 cell lines of human tumors. The compound 5.2 exhibits antitumor activity: CI50 2.68μM, LC50 31.7 μM (cell line MDA-MB-435 (Breast Cancer)); GI50 3.35 μM, LC50 37.6 μM (cell line OVCAR-3 (Ovarian Cancer)); GI50 6.75 μM, LC50 44.5 μM (cell line NCI-H23 (Non-small Cell Lung Cancer)).
Full text: (PDF, in Ukrainian)

References

[1] Omura S, Iwai Y, Hirano A, Nakagawa A, Awaya J, Tsuchya H, Takahashi Y, Masuma R. A new alkaloid AM-2282 OF Streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization. J Antibiot (Tokyo). 1977;30(4):275-82.
[2] Furusaki A, Hashiba N, Matsumoto T, Hirano A, Iwai Y, Omura S. X-Ray crystal structure of staurosporine: a new alkaloid from a Streptomyces strain. J Chem Soc, Chem Commun. 1978;(18):800.
[3] Furusaki A, Hashiba N, Matsumoto T, Hirano A, Iwai Y, Omura S. The crystal and molecular structure of staurosporine, a new alkaloid from a Streptomyces strain. Bull Chem Soc Jpn. 1982;55(12):3681–5.
[4] Fischer PM, Lane DP. Inhibitors of cyclin-dependent kinases as anti-cancer therapeutics. Curr Med Chem. 2000;7(12):1213-45.
[5] Senderowicz AM. The cell cycle as a target for cancer therapy: basic and clinical findings with the small molecule inhibitors flavopiridol and UCN-01. Oncologist. 2002;7 Suppl 3:12-9.
[6] Bailly C, Qu X, Chaires JB, Colson P, Houssier C, Ohkubo M, Nishimura S, Yoshinari T. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities. J Med Chem. 1999;42(15):2927-35.
[7] Andricopulo AD, Yunes RA, Nunes RJ, Savi AOS, Correa R, Cruz AB, Filho VC. Synthesis and antibacterial activity of cyclic imides: 3,4-dichloromaleimides and 4-substituted 3-chloromaleimides. Quim Nova. 1998; 21(5):573-7.
[8] Dubinina GG, Tarnavskyy SS, Golovach SM, Yarmoluk SM. Interaction of 3,4-dichloro maleimide along with N- and S- nucleophiles. Ukr Khim Zh. 2002; 68(8):47-51.
[9] Yarmoluk SM, Dubinina GG, Volovenko YM, Shishkina SV, Shishkin OV. Reaction of N-Substituted 3,4-Dichloromaleimides with a-Mercaptoazaheterocycles. Heterocycles. 2001;55(11):2189-98.